Nick Stephens, chief executive of RSA, outlines and analyses the major HR and people management issues global life sciences executives’ …
Netherlands-based diagnostics company Qiagen has made two appointments to its new pharma business development team. Dr Pia Gargiulo joins as …
Contract research and laboratory supplies giant Charles River has said it intends to purchase Chinese counterpart WuXi PharmaTech in a …

Pharma research company Synovate Healthcare has appointed Manfred Eberlein to head up its operations in Western Europe. In his new …

A new lighthearted game from The Kings Fund aims to educate players on the three main political parties’ health and …
Swiss firm Nycomed and Merck & Co have agreed to co-promote oral chronic obstructive pulmonary disease candidate Daxas in Europe. …
The first green shoots of recovery in the global economy – assuming of course they are not going to be …
The annual Interphex exhibition in New York was somewhat low-key this year with attendance disrupted by the block on flights …

UK medical device manufacturer Owen Mumford has appointed Paula Staples as global head of quality.She joins from pharma company Abbott, …
The UK general election debates turned to health policy on Thursday, with the Lib Democrats, Conservatives and Labour outlining their …

The internet and online developments such as YouTube, Twitter, Wikipedia and Facebook have already revolutionised how we communicate, and with …

Collie Turner has joined US word-of-mouth marketing agency HealthTalker’s leadership team as senior director of strategic partnerships. She will focus on driving new …

The FDA seems to have lost patience with biotechnology company Genzyme over contamination problems at its manufacturing facilities, levying a …
Irish drugmaker Elan says it is once again considering spinning out its drug delivery division, Elan Drug Technology, after abandoning …

German pharma company Bayer has ended its search for someone to replace healthcare chief executive Arthur Higgins, appointing Dr Jörg …
Novartis has had a very strong first quarter, its first under new chief executive Joe Jimenez, delivering a 25% increase …
Astellas Pharma Europe has set its sights on the oncology market, earmarking the therapy area as its latest “franchise focus” …
The headline news in the wake of the Icelandic volcano eruption has been of stranded passengers struggling to get home …
GlaxoSmithKline’s lupus treatment has failed to reach a statistically significant secondary endpoint in the second of two phase III trials. …

Red Kite has appointed Ursula Franklin to head up its new Transformation division. She joins from Wyeth Europa, now part …